CD19 and allergic rhinitis: Luo et al. reported changes in B cell subsets in allergic rhinitis, associating an increased percentage of terminally differentiated CD19+CD24hiCD38+cells, a subset of Bregs, with better clinical outcomes in patients receiving immunotherapy [51].